Sunscreen monograph amendment
This article was originally published in The Rose Sheet
Executive Summary
Labeling of sunscreen products introduced after Sept. 1 will need to reflect U.S. Pharmacopeia name changes for four active ingredients, FDA says in technical amendment published in the Federal Register June 20. Changes were proposed by the USP in 2000 based on names endorsed by the U.S. Adopted Names Council, FDA notes. Proposal was accepted in March 2001 and becomes effective Sept. 1. New names include meradimate for menthyl anthranilate; octinoxate for octyl methoxycinnamate; octisalate for octyl salicylate; and ensulizole for phenylbenzimidazole sulfonic acid. Comments on the amendment will be accepted until Aug. 19...
You may also be interested in...
Sunscreen Ingredient Name Change Required By Sept. 1
FDA will not take enforcement action against sunscreen manufacturers unable to re-label products to reflect required name changes for four ingredients before Sept. 1, the agency said in guidance to industry
Sunscreen Labeling Amendment Would Disrupt Product Supply – Industry
A Sept. 1 deadline for amending the names of four sunscreen ingredients on labeling would "unnecessarily disrupt the supply of sunscreen products," the Cosmetic, Toiletry & Fragrance Association and Consumer Healthcare Products Association tell FDA
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.